Speakers: Mary Moran (Policy Cures); Melvin Spigelman (TB Alliance); Sue Kinn (DFID); Paul Herrling (Novartis); a representative from the Gates Foundation
Chair: Andrew Jack (Financial Times)
Please register here
Join the report co-author, Dr Mary Moran, and international key commentators to discuss the report's findings and health funding decisions for the future. The G-FINDER survey, now in its seventh year, is the most comprehensive report to date on public, philanthropic and industry funding into R&D for neglected diseases like malaria, TB, HIV, pneumonia, sleeping sickness and helminth infections. This year, G-FINDER expanded to include hepatitis C genotype 4, cryptococcal meningitis and leptospirosis. It covers 34 diseases and 138 product areas for these, including drugs, vaccines, diagnostics, microbicides and vector control products. The G-FINDER survey is conducted by the independent research group Policy Cures and funded by the Bill & Melinda Gates Foundation. For more information regarding G-FINDER and Policy Cures, visit www.policycures.org or contact[email protected].
Hosted by Jeremy Lefroy MP, Chairman of the All-Party Parliamentary Group on Malaria & Neglected Tropical Diseases